As off-label use continues to expand, particularly among patients with obesity or insulin resistance, our findings suggest GLP-1based therapies may warrant consideration as an adjunct to insulin in carefully selected patients. Advertisement Advertisement New service for patients with diabetes will make annual screening more convenient Association revises criteria for the diagnosis and resolution of severe conditions What to consider in the management of euglycemic DKA Less than 50% of patients with diabetes get appropriate ophthalmic screening through primary care referrals Familiarity will enhance its accessibility for patients with diabetes New study counters earlier findings linking drugs with eye disease Study highlights the value of quantitative ultra-widefield angiography Longevity in healthcare, personal experiences may provide caregivers with false sense of confidence
They cause blood sugar spikes, provide empty calories, and can actually work against your GLP-1 medications benefits
Treatment months 7 through 12: transformation and maintenance The focus during the second half of the first year shifts toward body recomposition and maintenance planning
Liposomal glutathione, often hailed as the body's "master antioxidant," plays a pivotal role in combating oxidative stress and supporting various physiological functions
This is really, really wonderful
Conclusion The exploration of GLP-1 and GLP-2 pathways has provided an emerging hypothesis and therapeutic rationale for intestinal repair in IBD
